Online Learning Portal on Under Five Pneumonia (NCT04495361) | Clinical Trial Compass
CompletedNot Applicable
Online Learning Portal on Under Five Pneumonia
Pakistan600 participantsStarted 2019-04-01
Plain-language summary
Despite the availability of standard pneumonia management guidelines and multiple global efforts, pneumonia continues to be the leading killer of children under five, accounting to around 17% of the total under five deaths globally. In Pakistan, pneumonia contributes to 16% of under five mortality in the country having a well-defined yet poorly functional healthcare system.
Although, there are standard set of guidelines for management of pneumonia patients however, the management practices of this illness are variable across the country. This could be attributed to non-availability of work ready graduates which in turn is due to variations of teaching methods across various institutions. Although the medical students across these institutions do get exposed to clinical cases in the final year however, this exposure is also variable. If this clinical experience is coupled with an adjunct capacity building mode using an online platform. there is a possibility that students could be trained in a better way.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Inclusion Criteria for medical students:
* Final year medical students studying in institutions in Rawalpindi/Islamabad registered under the higher education commission
* Medical students whose heads have provided permission to undertake the study with them
* Medical students who have provided a written consent to be included in the study.
Inclusion Criteria for pneumonia patients
* Patients less than five years diagnosed with no pneumonia, pneumonia or severe pneumonia
* Parents/Carers who provide consent for their under five children to be videotaped.
Exclusion Criteria:
Exclusion Criteria fro medical students
* Medical students withdrawing/leaving the institute
* Medical students who are not in final year
Exclusion Criteria for pneumonia patients
* Patients under five suffering from comorbidity with pneumonia
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change from baseline knowledge of all participants on under five pneumonia at 6 months
Timeframe: 6 months
2
Change from baseline confidence in skills of all participants in diagnosing and managing under five pneumonia at 6 months